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Inflammatory Disease
(1) What Is Inflammation?
Hidehito Kato
Department of Microbiology and Immunology, Tokyo Women’s Medical University, Tokyo, Japan
Stress responses are part of an important system in maintaining the homeostasis of a living organism. After acute
inflammation, if tissue repair is incomplete or stress is not completely removed with an excessive and prolonged
inflammatory response, damage is accumulated in living organs and chronic inflammation persists. Thus, irre-
versible tissue and organ damage occurs, which is accompanied by fibrosis. Further, inflammatory diseases, such
as fibrotic diseases, autoimmune diseases, allergies, and arteriosclerosis, account for most causes of deaths in hu-
mans; therefore, it is extremely important to understand mechanisms of inflammation and to establish a control
method. Inflammation is caused by a complex influence of various molecules and cells that form networks
through inflammatory cytokines. Since various factors influence each other, the onset time, degree, and duration
of inflammation may differ. This article explains the mechanism of inflammation, presents findings on its regula-
tory factors and methods, and enumerates the innate immune system receptors (pattern recognition receptors)
and responsible cells (neutrophils, innate lymphoid cells, natural killer T cells) that cause inflammation. This arti-
cle thus aims to understand the complex networks involved in inflammation.
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でも nod-like receptor（NLR）familyや hematopoie-
tic interferon（IFN）-γ inducible nuclear protein with
the 200-amino-acid repeat（HIN-200）familyが，非自
己を認識して apoptosis-associated speck-like pro-




















































Figure　1　Classes of molecules that initiate innate and adaptive immune responses1).
The initiating events in inflammation and the resultant adaptive immune response include 
both pathogen-associated molecular patterns (PAMPs) and damage-associated molecular 
patterns (DAMPs). These are protein (e.g. HMGB1) or non protein (e.g. ATP, uric acid) 
molecules which in healthy conditions are confined within cells but are delivered outside 
upon cell damage, such as necrosis, and in some instances secreted by cells. The levels of 
released DAMPs depend on the abundance of intracellular DAMPs and are often higher 
and enduring in neoplastic tissues than in normal tissues. This leads to persistent inflam-
mation. Other sources of DAMPs include degraded extracellular matrix, such as heparan 
sulphate and hyaluronan. Many of the receptors so far identified for DAMPs and PAMPs 
are shared, and belong to the family of Pattern Recognition Receptors, PRRs. Therefore, 
both sterile and non sterile inflammation signals converge on a common pathway. Matz-
inger has suggested a unique integrating hypothesis that all molecules signaling danger 
or damage are DAMPs, with hydrophobic portions of molecules (HYPPOs) derived either 
from dead and dying host cells or pathogens68) 69).
LPS, lipopolysaccharide; ssRNA, single strand RNA; T. gondii, Trypanasoma gondii (proto-
zoan parasite); HMGB1, high mobility group box 1 protein; PRRs, pattern recognition recep-






















Figure　2　Mechanisms involved in T-cell inhibition (left panel) and activation (right panel) 
by neutrophils13).
Neutrophils can establish T-cell inhibition by (1) degranulation of granular constituents. 
The serine proteases elastase and cathepsin G inactivate T-cell stimulating cytokines, IL-2 
and IL-6, and catalyze shedding of cytokine receptors for IL-2 and IL-6 on T-cells14) 15). (2) 
Production of reactive oxygen species (ROS) and release of arginase. Both agents can result 
in downregulation of TCR ζ on T-cells, thereby arresting the cell in the G0-G1 phase16) ～ 21). 
(3) Expression of PD-L1. Upregulation of this ligand is associated with interferon-dependent 
PD1-mediated T-cell apoptosis22) 23). T-cell activation by neutrophils is attained by (4) indi-
rect antigen presentation. Dendritic cells take up antigens from apoptotic neutrophils and 
serve as APC for T-cells24). (5) Direct antigen presentation. Neutrophils possess the capacity 
to cross-prime CD8+ T-cells directly in a MHCI-dependent manner25). (6) Release of microbi-

















外を II型と呼ぶ．大部分の NKT細胞は I型であり
―5―
Figure　3　Overview of the different functional human NKT cell subsets41).
CD1d-restricted human NKT cells can be divided into subsets based on their TCR reper-
toire and cytokine profile. Type I NKT cells express the invariant Vα24Jα18 TCR α-chain 
and can be subdivided into five distinct functional subsets (indicated in green). In addi-
tion, type II NKT cells express a diverse TCR repertoire and can be subdivided into two 
functional subsets (indicated in blue). Upon activation, NKT cells secrete a unique pattern 
of cytokines, indicated for each subtype. Type I and type II NKT cells are able to switch 
between different functional subsets upon interactions within the TME. 
NKT, natural killer T; TCR, T cell receptor; TH, helper T; T reg, regulatory T; TFH, fol-
licular helper T; TME, tumor microenvironment. 
I型の TCRには多様性がないため，invariant NKT
























1）Leukocyte cell-derived chemotaxin-2（LECT 2）


















肝炎が野生型マウスに比べ LECT 2 knock out（KO）
マウスにおいて増悪することを見出した４４）．肝臓の




Figure　4　Plasma cytokine/chemokine levels are increased in a Staphyiococcal entero-
toxin A (SEA)-dose dependent manner, thereby influencing prognosis46). 
(A) B6mice were injected with 0.1 and 1.0 μg SEA/D-GalN, and the plasma levels of the 
indicated cytokines and a chemokine were followed for 72 h after treatment. Data are pre-
sented as the mean ± SD of 3 samples at each time point. (B) B6 mice were injected with 1.0 
μg SEA/D-GalN, and blood samples were collected at 12 h thereafter. The mice were then 
observed, and blood samples were again collected from the mice still alive at 72 h thereaf-
ter. The indicated plasma cytokine/chemokine levels were compared among the control, 
surviving and dead mice. Data are presented as the mean ± SD of the indicated number 
of samples. ＊p<0.05, ＊＊p<0.01, ＊＊＊p<0.005. 
（2）抗コラーゲン抗体誘導性関節炎の抑制




































Figure　5　Administration of leukocyte cell-derived chemotaxin-2 (LECT 2) reduces lethal-
ity after treatment with Staphyiococcal enterotoxin A (SEA)/D-GalN in a manner that is 
associated with theinhibition of cytokines in plasma46).
 (A) B6 mice were injected with 5 μg of rLECT2 protein (Treated, n=15) or PBS (Untreated, 
n=15) as acontrol at 0.5 h and 6 h after treatment with 1.0 μg SEA/D-GalN, and the surviv-
al rate was examined 72 h later. (B) Indicated plasmacytokine/chemokine levels in B6 mice 
compared at 12 h after treatment. Data are presented as the mean ± SD of 3 samples. ＊
p<0.05. 













































Figure　6　Liver inflammation is critical for β-catenin-induced liver tumorigenesis49). 
Oncogenic activation of β-catenin in hepatocytes triggers an intrinsic inflammatory pro-
gram with both pro- and anti-inflammatory mediators that together construct an inflam-
matory microenvironment that controls tumor progression. In Apc-deficient (Apc-/-) 
hepatocytes, β-catenin signaling is constitutively activated and induced: (a) the expression 
of a proinflammatory program resulting from both a direct control by the Wnt/β-catenin 
signaling and an indirect control by NF-κB that is not yet understood and (b) the expres-
sion of an anti-inflammatory program including at least the direct leukocyte cell-derived 
chemotaxin-2 (LECT2) target gene. 2 interconnected factors relay the anti-inflammatory 
response, the chemokine-like factor LECT2 and the iNKT cells. iNKT cell homeostasis is 
controlled by LECT2 at the level of liver homing and cytokine polarization. Together, the 
β-catenin-induced liver microenvironment exhibits a low grade of chronic inflammation 
that preserves an immune response with antitumor activity. In mice deficient in Apc and 
LECT2 (Apc-/-LECT2-/-), the lack of LECT2 causes highgrade inflammation in the liver 







































6）Regulatory dendritic cells（DC regs）
Satoらは未熟樹状細胞に各種の刺激を加えるこ
とにより，regulatory T（T reg）細胞誘導能等の T



















supression of tumorigenicity（ST）2に 結 合 し て
GRK2の発現を抑制しているが，致死的な敗血症患

















































Figure　7　IL-33 promotes the migration of neutrophils into the focus of infection60). 
Detection of microbes by Toll-like receptors (TLRs) expressed by neutrophils increases the 
expression of G protein-coupled receptor kinase (GRK) 2. GRK2 mediates the internalization 
of (C-X-C motif chemokine) receptor (CXCR) 2 and desensitizes neutrophils to the action of 
the chemokines (C-X-C motif chemokine) ligand (CXCL) 2 and CXCL8, produced by mono-
cytes/macrophages, epithelial cells and endothelial cells at the focus of infection. The cy-
tokine IL-33, expressed by fibroblasts and epithelial, endothelial, mast and innate immune 
cells in response to infection, signals through a receptor complex composed of soluble su-
pression of tumorigenicity (ST) 2 and IL-1 receptor accessory protein (IL-1RAP). IL-33 also 
binds a soluble isoform of ST2 (sST2) that acts as a decoy receptor. sST2 is upregulated in 
people with sepsis and functions as a modulator of IL-33. Alves-Filho et al. report that IL-33 
lowers the expression of GRK2, overriding the downregulation of CXCR2 and the inhibition 
of neutrophil chemotaxis induced by TLR agonists59). This signaling cascade enhances anti-
microbial host defenses. 
母マウスへの抗生物質投与は，新生仔マウスの腸管
























Figure　8　Timing of morphine administration affects the 
survival rate of mice with LPS-mediated lethal endotoxic
shock61).
The administration schedule is shown in (A). Mice were
sensitized with α-GalCer (2 mg/mouse) 24 h before the 
LPS (1.5 mg/mouse) challenge. A, Mice were administered
0.8 mg of morphine or PBS at 0.5 h before or after the LPS 
challenge. B, The survival rate was observed every hour
for 72 h. Each group comprised 10 mice. The significance
of the difference between the survival rates of each test
group and the respective control group was evaluated us-
ing the Wilcoxon test.

































1）Rubartelli A, Lotze MT : Inside, outside, upside
down: damage-associated molecular-pattern mole-
cules (DAMPs) and redox. Trends Immunol 28 (10):
429―436, 2007
2）Schroder K, Tschopp J: The inflammasomes. Cell
140: 821―832, 2010
3）Fang R, Tsuchiya K, Kawamura I et al: Critical
roles of ASC inflammasomes in caspase-1 activation
and host innate resistance to Streptococcus pneu-
moniae infection. J Immunol 187: 4890―4899, 2011
4）Vandanmagsar B, Youm YH, Ravussin A et al:
The NLRP 3 inflammasome instigates obesity-
induced inflammation and insulin resistance. Nat
Med 17: 179―188, 2011
5）Davis BK, Wen H, Ting JP : The inflammasome
NLRs in immunity, inflammation, and associated
diseases. Annu Rev Immunol 29: 707―735, 2011
6）Takeuchi O, Akira S : Pattern recognition recep-
tors and inflammation. Cell 140: 805―820, 2010
7）Brinkmann V, Reichard U, Goosmann C et al:
Neutrophil extracellular traps kill bacteria. Science
303: 1532―1535, 2004
8）Parker H, Albrett AM, Kettle AJ et al: Myeloper-
oxidase associated with neutrophil extracellular
traps is active and mediates bacterial killing in the
presence of hydrogen peroxide. J Leukoc Biol 91 :
369―376, 2012
9）Li P, Li M, Lindberg MR et al: PAD4 is essential
for antibacterial innate immunity mediated by neu-
trophil extracellular traps. J Exp Med 207 : 1853―
1862, 2010
10）Fuchs TA, Brill A, Duerschmied D et al: Extracel-
lular DNA traps promote thrombosis. Proc Natl
Acad Sci U S A 107: 15880―15885, 2010
11）Cools-Lartigue J, Spicer J, McDonald B et al:
―12―
Neutrophil extracellular traps sequester circulating
tumor cells and promote metastasis. J Clin Invest
123: 3446―3458, 2013
12）Knight JS, Zhao W, Luo W et al: Peptidylarginine
deiminase inhibition is immunomodulatory and vas-
culoprotective in murine lupus. J Clin Invest 123 :
2981―2993, 2013
13）Leliefeld PH, Koenderman L, Pillay J : How neu-
trophils shape adaptive immune responses. Front
Immunol 6: 471 (1-8), 2015
14）Bank U, Reinhold D, Schneemilch C et al: Selec-
tive proteolytic cleavage of IL-2 receptor and IL-6
receptor ligand binding chains by neutrophil-
derived serine proteases at foci of inflammation. J
Interferon Cytokine Res 19: 1277―1287, 1999
15）Bank U, Ansorge S : More than destructive :
neutrophil-derived serine proteases in cytokine bio-
activity control. J Leukoc Biol 69: 197―206, 2001
16）Pillay J, Kamp VM, van Hoffen E et al: A subset
of neutrophils in human systemic inflammation in-
hibits T-cell responses through Mac-1. J Clin Invest
122: 327―336, 2012
17）Rodriguez PC, Quiceno DG, Ochoa AC: L-arginine
availability regulates T-lymphocyte cell-cycle pro-
gression. Blood 109: 1568―1573, 2007
18）Makarenkova VP, Bansal V, Matta BM et al: CD
11b+/Gr-1+myeloid suppressor cells cause T cell
dysfunction after traumatic stress. J Immunol 176 :
2085―2094, 2006
19）Yachimovich-Cohen N, Even-Ram S, Shufaro Y
et al: Human embryonic stem cells suppress T cell
responses via arginase I-dependent mechanism. J
Immunol 184: 1300―1308, 2010
20）Gelderman KA, Hultqvist M, Holmberg J et al: T
cell surface redox levels determine T cell reactivity
and arthritis susceptibility. Proc Natl Acad Sci U S
A 103: 12831―12836, 2006
21）Malmberg KJ, Arulampalam V, Ichihara F et al:
Inhibition of activated/memory (CD45RO+) T cells
by oxidative stress associated with block of NF-
kappaB activation. J Immunol 167: 2595―2601, 2001
22）de Kleijn S, Langereis JD, Leentjens J et al: IFN-γ-
stimulated neutrophils suppress lymphocyte prolif-
eration through expression of PD-L1. PLoS One 8: e
72249, 2013
23）Hotchkiss RS, Monneret G, Payen D : Sepsis-
induced immunosuppression: from cellular dysfunc-
tions to immunotherapy. Nat Rev Immunol 13: 862―
874, 2013
24）Schuster S, Hurrell B, Tacchini-Cottier F : Cros-
stalk between neutrophils and dendritic cells : a
context-dependent process. J Leukoc Biol 94 : 671―
675, 2013
25）Hufford MM, Richardson G, Zhou H et al:
Influenza-infected neutrophils within the infected
lungs act as antigen presenting cells for anti-viral
CD8+ T cells. PLoS One 7: e46581, 2012
26）Davey MS, Lin CY, Roberts GW et al: Human
neutrophil clearance of bacterial pathogens trig-
gers anti-microbial γδ T cell responses in early in-
fection. PLoS Pathog 7: e1002040, 2011
27）Sonnenberg GF, Artis D: Innate lymphoid cells in
the initiation, regulation and resolution of inflamma-
tion. Nat Med 21 (7): 698―708, 2015
28）Spits H, Artis D, Colonna M et al: Innate lymphoid
cells--a proposal for uniform nomenclature. Nat Rev
Immunol 13: 145―149, 2013
29）Halim TY, MacLaren A, Romanish MT et al:
Retinoic-acid-receptor-related orphan nuclear re-
ceptor alpha is required for natural helper cell de-
velopment and allergic inflammation. Immunity 37:
463―474, 2012
30）Salimi M, Barlow JL, Saunders SP et al: A role
for IL-25 and IL-33-driven type-2 innate lymphoid
cells in atopic dermatitis. J Exp Med 210: 2939―2950,
2013
31）Halim TY, Steer CA, Mathä L et al: Group 2 in-
nate lymphoid cells are critical for the initiation of
adaptive T helper 2 cell-mediated allergic lung in-
flammation. Immunity 40: 425―435, 2014
32）Matsuda JL, Naidenko OV, Gapin L et al: Track-
ing the response of natural killer T cells to a glycol-
ipid antigen using CD1d tetramers. J Exp Med 192
(5): 741―754, 2000
33）Godfrey DI, Kronenberg M: Going both ways: im-
muneregulation via CD1d-dependent NKT cells. J
Clin Invest 114 (10): 1379―1388, 2004
34）Brennan PJ, Brigl M, Brenner MB : Invariant
natural killer T cells: an innate activation scheme
linked to diverse effector functions. Nat Rev Immu-
nol 13 (2): 101―117, 2013
35）Brutkiewicz RR: CD1d ligands: the good, the bad,
and the ugly. J Immunol 177 (2): 769―775, 2006
36）Tupin E, Kinjo Y, Kronenberg M: The unique role
of natural killer T cells in the response to microor-
ganisms. Nat Rev Microbiol 5 (6): 405―417, 2007
37）Bendelac A, Savage PB, Teyton L: The biology of
NKT cells. Annu Rev Immunol 25: 297―336, 2007
38）Chang DH, Deng H, Matthews P et al:
Inflammation-associated lysophospholipids as
ligands for CD1 d-restricted T cells in human can-
cer. Blood 112: 1308―1316, 2008
39）Zhou D, Mattner J, Cantu C 3rd et al: Lysosomal
glycosphingolipid recognition by NKT cells. Sci-
ence 306: 1786―1789, 2004
40）La Cava A, Van Kaer L, Fu-Dong-Shi : CD4 +
CD25+ Tregs and NKT cells: regulators regulating
regulators. Trends Immunol 27 (7): 322―327, 2006
41）Gonzalez-Aseguinolaza G, Van Kaer L,
Bergmann CC et al: Natural killer T cell ligand
alpha-galactosylceramide enhances protective im-
munity induced by malaria vaccines. J Exp Med
195: 617―624, 2002
42）Sag D, Krause P, Hedrick CC et al: IL-10-
producing NKT10 cells are a distinct regulatory in-
variant NKT cell subset. J Clin Invest 124 (9): 3725―
3740, 2014
43）Yamagoe S, Yamakawa Y, Matsuo Y et al: Purifi-
cation and primary amino acid sequence of a novel
neutrophil chemotactic factor LECT 2. Immunol
Lett 52: 9―13, 1996
44）Saito T, Okumura A, Watanabe H et al: Increase
―13―
in hepatic NKT cells in leukocyte cell-derived che-
motaxin 2-deficient mice contributes to severe con-
canavalin A-induced hepatitis. J Immunol 173: 579―
585, 2004
45）Okumura A, Saito T, Otani I et al: Suppressive
role of leukocyte cell-derived chemotaxin 2 in
mouse anti-type II collagen antibody-induced ar-
thritis. Arthritis Rheum 58: 413―421, 2008
46）Dang MH, Kato H, Ueshiba H et al: Possible role
of LECT2 as an intrinsic regulatory factor in SEA-
induced toxicity in d-galactosamine-sensitized mice.
Clin Immunol 137 (3): 311―321, 2010
47）Ando K, Kato H, Kotani T et al: Plasma leukocyte
cell-derived chemotaxin 2 is associated with the se-
verity of systemic inflammation in patients with
sepsis. Microbiol Immunol 56: 708―718, 2012
48）Phesse TJ, Parry L, Reed KR et al: Deficiency of
Mbd2 attenuates Wnt signaling. Mol Cell Biol 28 :
6094―6103, 2008
49）Anson M, Crain-Denoyelle AM, Baud V et al: On-
cogenic β-catenin triggers an inflammatory re-
sponse that determines the aggressiveness of hepa-
tocellular carcinoma in mice. J Clin Invest 122 (2) :
586―599, 2012
50）Lan F, Misu H, Chikamoto K et al: LECT2 func-
tions as a hepatokine that links obesity to skeletal
muscle insulin resistance. Diabetes 63 ( 5 ) : 1649―
1664, 2014
51）Mantovani A, Sica A, Sozzani S et al: The
chemokine system in diverse forms of macrophage
activation and polarization. Trends Immunol 25 :
677―686, 2004
52）Takayanagi H, Ogasawara K, Hida S et al: T-cell-
mediated regulation of osteoclastogenesis by signal-
ling cross-talk between RANKL and IFN-gamma.
Nature 408: 600―605, 2000
53）Maruyama K, Takada Y, Ray N et al: Receptor
activator of NF-kappa B ligand and osteoprotegerin
regulate proinflammatory cytokine production in
mice. J Immunol 177: 3799―3805, 2006
54）Inatsu A, Kinoshita M, Nakashima H et al: Novel
mechanism of C-reactive protein for enhancing
mouse liver innate immunity. Hepatology 49: 2044―
2054, 2009
55）Nakahashi-Oda C, Tahara-Hanaoka S, Honda S
et al: Identification of phosphatidylserine as a
ligand for the CD300a immunoreceptor. Biochem
Biophys Res Commun 417 (1): 646―650, 2012
56）Nakahashi-Oda C, Tahara-Hanaoka S, Shoji M et
al: Apoptotic cells suppress mast cell inflammatory
responses via the CD300a immunoreceptor. J Exp
Med 209 (8): 1493―1503, 2012
57）Sato K, Yamashita N, Yamashita N et al: Regula-
tory dendritic cells protect mice from murine acute
graft-versus-host disease and leukemia relapse. Im-
munity 18: 367―379, 2003
58）Fujita S, Seino K, Sato K et al: Regulatory den-
dritic cells act as regulators of acute lethal systemic
inflammatory response. Blood 107: 3656―3664, 2006
59）Alves-Filho JC, Sônego F, Souto FO et al:
Interleukin-33 attenuates sepsis by enhancing neu-
trophil influx to the site of infection. Nat med 16 (6):
708―712, ONLINE METHODS, 2010
60）Roger T, Calandra T : Interleukin-33 safeguards
neutrophils in sepsis. Nat Med 16 (6): 638―639, 2010
61）Fukada T, Kato H, Ozaki M et al: Impact of the
timing of morphine administration on
lipopolysaccharide-mediated lethal endotoxic shock
in mice. Shock 45 (5): 564―569, 2016
62）Xu J, Zhang X, Pelayo R et al: Extracellular his-
tones are major mediators of death in sepsis. Nat
Med 15: 1318―1321, 2009
63）Deshmukh HS, Liu Y, Menkiti OR et al: The mi-
crobiota regulates neutrophil homeostasis and host
resistance to Escherichia coli K1 sepsis in neonatal
mice. Nat Med 20: 524―530, 2014
64）Tabas I, Glass CK : Anti-inflammatory therapy in
chronic disease: challenges and opportunities. Sci-
ence 339 (6116): 166―172, 2013
65）Landskron G, De la Fuente M, Thuwajit P et al:
Chronic inflammation and cytokines in the tumor
microenvironment. J Immunol Res 2014 : 149185,
2014
66）Pikarsky E, Porat RM, Stein I et al: NF-kappa B
functions as a tumour promoter in inflammation-
associated cancer. Nature 431: 461―466, 2004
67）Oshima H, Nakayama M, Han TS et al: Suppress-
ing TGFβ signaling in regenerating epithelia in an
inflammatory microenvironment is sufficient to
cause invasive intestinal cancer. Cancer Res 75 (4):
766―776, 2015
68）Matzinger P: The danger model: a renewed sense
of self. Science 296 (5566): 301―305, 2002
69）Seong SY, Matzinger P : Hydrophobicity : an an-
cient damage-associated molecular pattern that in-
itiates innate immune responses. Nat Rev Immunol
4 (6): 469―478, 2004
